Journal article
RIPK1 is not essential for TNFR1-induced activation of NF-κB
WWL Wong, IE Gentle, U Nachbur, H Anderton, DL Vaux, J Silke
Cell Death and Differentiation | Published : 2010
DOI: 10.1038/cdd.2009.178
Abstract
On TNF binding, receptor-interacting protein kinase 1 (RIPK1) is recruited to the cytoplasmic domain of TNFR1, at which it becomes ubiquitylated and serves as a platform for recruitment and activation of NEMO/IKK1/IKK2 and TAK1/TAB2. RIPK1 is commonly thought to be required for the activation of canonical NF-B and for inhibition TNFR1-induced apoptosis. RIPK1 has, however, also been reported to be essential for TNFR1-induced apoptosis when cIAPs are depleted. To determine the role of RIPK1 in TNF/IAP antagonist-induced death, we compared wild type (WT) and RIPK1-/-mouse embryonic fibroblasts (MEFs) treated with these compounds. On being treated with TNF plus IAP antagonist, RIPK1 -/-MEFs sur..
View full abstractGrants
Awarded by Leukemia and Lymphoma Society
Funding Acknowledgements
We thank Michelle Kelliher for providing RIPK1<SUP>-/-</SUP> mice; Heinrich Korner for providing TNFR1<SUP>-/-</SUP> and TNFR2<SUP>-/-</SUP> mice; M McKinlay for supplying IAP antagonist, comp A (TetraLogic Pharmaceuticals); JE Vince for critical reading of the paper. JS is funded by the NHMRC (433013, 541901 and 541902). DLV is an NHMRC Australian Fellow, funded by the Leukemia and Lymphoma Society and the NHMRC (461221). IEG is funded by NHMRC Australian Postdoctoral Training Fellowship (487348). UN is funded by Swiss National Science Foundation.